Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Could Invokana have been the cause of my lower-limb amputation?

September 15, 2017 By Law Offices of Thomas J. Lamb, P.A.

The FDA is investigating a connection between diabetes drugs belonging to the Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors class of drugs and the following side effects: Diabetic Ketoacidosis (DKA) Ketoacidosis Ketosis Acute Kidney Injury Kidney Failure / Renal Failure Kidney Damage Pyelonephritis (kidney infection) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, amputation risk factors, blood infection, diabetes drugs, diabetic ketoacidosis, DKA, drug injury lawsuits, Farxiga, Foot Amputation, Glyxambi, Invokamet, Invokana, Jardiance, Ketoacidosis, Ketosis, Kidney Damage, Kidney Failure, kidney infection, Leg Amputation, Pyelonephritis, Qtern, Renal Failure, sglt2 inhibitors, side effects of diabetes drugs, Sodium-Glucose Co-Transporter-2 inhibitors, Synjardy, Toes Amputation, Urinary Tract Infection, Urosepsis, UTI, Xigduo

Can SGLT-2 Inhibitor Diabetes Drugs Increase Your Risk of Stroke?

June 21, 2017 By Law Offices of Thomas J. Lamb, P.A.

While we have frequently discussed DKA, kidney damage, and amputations as possible side effects of diabetes drugs in the SGLT-2 inhibitors class -- such as Farxiga, Invokana, Jardiance -- strokes and thromboembolic events are also considered potential harmful effects of these drugs. Based on FAERS reports received during the second quarter of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, Amputations, antidiabetic drugs, canagliflozin, canagliflozin/metformin HCl, causes of stroke, dapagliflozin, dapagliflozin/metformin HCl, Deep Vein Thrombosis, diabetes drugs, diabetic ketoacidosis, DKA, drug injury lawsuits, drug side effects, DVT, empagliflozin, empagliflozin/linagliptin, empagliflozin/metformin HCl, Farxiga, FDA, FDA FAERS reports, Glyxambi, Invokamet, Invokana, Jardiance, Kidney Damage, Kidney Failure, lower limb amputations, PE, Pulmonary Embolism, SGLT-2 inhibitors, Stroke, Synjardy, thromboembolic events, Xigduo, xigduo xr

Farxiga MDL Includes Diabetic Ketoacidosis And Kidney Damage Lawsuits

May 16, 2017 By Law Offices of Thomas J. Lamb, P.A.

On April 6, 2017 the United States Judicial Panel On Multidistrict Litigation (JPML) issued this document, “IN RE: FARXIGA (DAPAGLIFLOZIN) PRODUCTS LIABILITY LITIGATION TRANSFER ORDER — MDL No. 2776”, from which we get the following information: On the basis of the papers filed and the hearing session held, we find that these actions involve … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Diabetic Ketoacidosis (DKA), Farxiga, Glyxambi, Invokamet, Invokana, Jardiance, Kidney Damage, Qtern, Synjardy, Xigduo

Federal Court Invokana MDL In New Jersey With Judge Brian Martinotti

March 17, 2017 By Law Offices of Thomas J. Lamb, P.A.

Invokana (canagliflozin) was approved by the FDA in 2013.  Invokamet (canagliflozin and metformin) was approved by the FDA in 2014.  Both of these drugs were approved for use by patients with Type 2 diabetes. In December 2015 the FDA issued this Drug Safety Communication: “FDA revises labels of SGLT2 inhibitors for diabetes to include warnings … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, diabetes drugs, Diabetic Ketoacidosis (DKA), Invokamet, Invokana, Ketoacidosis, Kidney Damage, type 2 diabetes drugs

Prevacid, Nexium, And Prilosec Linked To Risk Of Chronic Kidney Damage

February 27, 2017 By Law Offices of Thomas J. Lamb, P.A.

A recent medical study done by medical researchers in St. Louis, Missouri indicates that more than half of those patients who develop chronic kidney damage (CKD) while using proton pump inhibitors (PPIs) heartburn drugs and acid reflux medicines do not experience acute kidney problems before their CKD diagnosis. These researchers published their … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, chronic kidney disease, Kidney Damage, Kidney Disease, Kidney Failure, kidney injury, Nexium, Prevacid, Prilosec, Renal Failure

December 2016: FDA Requires Safety Warnings Label Change For Jardiance

December 20, 2016 By Law Offices of Thomas J. Lamb, P.A.

After the December 2, 2016 decision by the FDA decision by U.S. regulators to expand the health benefits for the relatively new diabetes medicine Jardiance (empagliflozin) to include preventing fatal heart attacks and strokes in type 2 diabetes patients, we saw news reports about its expected effect on Jardiance sales in the U.S. From this … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, drug injury, drug side effects, FDA, Jardiance, Ketoacidosis, Kidney Damage, Kidney Failure, mesothelioma

Farxiga / Jardiance / Invokana: Label Change Adds Ketoacidosis Warning

August 31, 2016 By Law Offices of Thomas J. Lamb, P.A.

In August 2016 the FDA sent letters to Janssen Pharmaceuticals and AstraZeneca Pharmaceuticals for label changes about fatal cases of ketoacidosis cases involving Invokana (canagliflozin), Invokamet (canagliflozin and metformin), Farxiga (dapagliflozin), and Xigduo XR (dapagliflozin and metformin extended-release). As for the other diabetes … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, Cerebral Vascular Accident (CVA), Deep Vein Thrombosis (DVT), Farxiga, Glyxambi, Heart Attacks, Invokamet, Invokana, Ischemic Stroke, Jardiance, Ketoacidosis, Kidney Damage, Kidney Failure, Myocardial Infarctions (MI), Pulmonary Embolism (PE), Pyelonephritis, Renal Failure, Synjardy, Urinary Tract Infection (UTI), Urosepsis, Xigduo

Nexium / Prevacid / Prilosec Series: The Devastating Side Effects

August 22, 2016 By Law Offices of Thomas J. Lamb, P.A.

In the first article of the Nexium, Prevacid, Prilosec Series, I gave a brief overview of some of the possible side effects of these PPI drugs.  I will now expand on this previous discussion to provide more detailed information about these conditions.  Please know that I am not qualified to give medical advice, and am simply summarizing recent … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Interstitial Nephritis, Acute Kidney Injury, ain, aki, AstraZeneca Pharmaceuticals, chronic kidney disease, ckd, drug injury, drug side effects, end stage renal disease, esrd, failure to warn, FDA, Kidney Damage, Kidney Failure, Nexium, ppi drugs, Prevacid, Prilosec, proton pump inhibitors, Renal Failure, Takeda Pharmaceuticals America

Nexium / Prevacid / Prilosec Series: Overview and Background

August 11, 2016 By Law Offices of Thomas J. Lamb, P.A.

To start my series on Nexium, Prevacid, and Prilosec, I would like to provide some background information on these drugs, as well as a quick overview of their detrimental side-effects. For many years, popular heartburn and acid reflux drugs like Nexium, Prilosec, and Prevacid have been touted as safe by the drug manufacturers and doctors alike. … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Interstitial Nephritis, Acute Kidney Injury, ain, aki, AstraZeneca Pharmaceuticals, chronic kidney disease, ckd, drug injury, drug side effects, end stage renal disease, esrd, failure to warn, FDA, Kidney Damage, Kidney Failure, Nexium, ppi drugs, Prevacid, Prilosec, proton pump inhibitors, Renal Failure, Takeda Pharmaceuticals America

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.